18 Result(s)

Article

Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring

Between 1982 and 1991, 41 patients were treated for non HIV related primary cerebral lymphoma (PCL) in our institute. The purpose of this study was to perform a multivariate analysis of prognostic factors for ...

J-Y Blay, C Lasset, C Carrie, F Chauvin, B Coiffier… in British Journal of Cancer (1993)

Article

Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients

A prospective study was performed to assess the use of plasma measurement of tumour necrosis factor (TNF), lymphotoxin alpha (LT alpha) and their soluble receptors (p55 and p75) for prognostic risk assignment ...

K Warzocha, J Bienvenu, P Ribeiro, I Moullet, C Dumontet… in British Journal of Cancer (1998)

Article

Mantle cell lymphoma: a retrospective study of 121 cases

Mantle cell lymphoma (MCL) patients represent a difficult problem, sometimes to establish the diagnosis but mostly because of their refractoriness to standard lymphoma treatments. Which treatments to apply and...

H Samaha, C Dumontet, N Ketterer, I Moullet, C Thieblemont, F Bouafia… in Leukemia (1998)

Article

Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome

Unbalanced translocations involving chromosome arm 17p, where the TP53 tumor suppressor gene localizes, are rarely described in chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL), but recent...

E Callet-Bauchu, G Salles, S Gazzo, C Poncet, D Morel, J Pagès, B Coiffier… in Leukemia (1999)

Article

Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin’s lymphoma

Serum lactic dehydrogenase (LDH) is an important prognostic factor in patients with non-Hodgkin’s lymphoma (NHL). We have examined the LDH isoenzyme content in serum and CSF of patients with NHL, at diagnosis ...

C Dumontet, J Drai, J Bienvenu, E Neidhardt Berard, C Thieblemont, F Bouafia… in Leukemia (1999)

Article

A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles… in Leukemia (2000)

Article

Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia

Progressive multifocal leukoencephalopathy (PML) is related to central nervous system infection with JC virus (JCV). This leukoencephalopathy occurs in immunocompromised patients such as those with acquired i...

O. Hequet, G. Salles, D. Espinousse, C. Dumontet, F. Bouafia… in Annals of Hematology (2002)

Article

Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis

C Thieblemont, K Chettab, P Felman, E Callet-Bauchu, A Traverse-Glehen… in Leukemia (2002)

Article

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

With the introduction of new drugs such as alpha-interferon (IFN) and purine analogs, the management of hairy cell leukemia (HCL) patients has changed. However, deoxycoformycin (DCF) produced higher complete r...

F Maloisel, L Benboubker, M Gardembas, B Coiffier, M Divine, C Sebban, M Blanc… in Leukemia (2003)

Article

FcγRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP)

S Camilleri-Broët, N Mounier, A Delmer, J Brière, O Casasnovas, L Cassard… in Leukemia (2004)

Article

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases

The purpose of this study was to document the frequency and distribution of karyotypic changes present at diagnosis in 103 non-MALT marginal zone cell lymphoma (MZL) patients. This cytogenetic analysis of a la...

E Callet-Bauchu, L Baseggio, P Felman, A Traverse-Glehen, F Berger, D Morel… in Leukemia (2005)

Article

Rituximab therapy in malignant lymphoma

Rituximab is the first monoclonal antibody to have been registered for the treatment of B-cell lymphomas. Randomized studies haves demonstrated its activity in follicular lymphoma (FL), mantle cell lymphoma an...

B Coiffier in Oncogene (2007)

Article

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin

A Traverse-Glehen, A Verney, L Baseggio, P Felman, E Callet-Bauchu… in Leukemia (2007)

Article

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an increasing number of publications have dealt with multiple aspects of SMZL diagnosis, molecular pathogenesis and treatment. Th...

E Matutes, D Oscier, C Montalban, F Berger, E Callet-Bauchu, A Dogan, P Felman… in Leukemia (2008)

Article

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab

Gene expression profiles have been associated with clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with anthracycline-containing chemotherapy. Using Affymetrix HU133A microarray...

J-P Jais, C Haioun, T J Molina, D S Rickman, A de Reynies, F Berger… in Leukemia (2008)

Article

Phase 1b study of lenalidomide in combination with rituximab-CHOP (R2-CHOP) in patients with B-cell lymphoma

H Tilly, F Morschhauser, G Salles, R-O Casasnovas, P Feugier, T J Molina… in Leukemia (2013)